ArticleAnnals of translational medicine2016

Afatinib for patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer: clinical implications of the LUX-Lung 7 study.

Keunchil ParkPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.